PICS SCALE UP
CHALLENGE
Cowpeas, better known as black-eyed peas in the US, are rich in protein and amino acids, and a major crop for millions of smallholder farmers across Africa.
Farmers lose an estimated 25% of their crop to pests during storage after harvest. Conventional storage methods to reduce crop losses involve expensive and potentially toxic pesticides. Because these storage solutions are inadequate, farmers are required to sell soon after harvest, which results in lost income due to low prices from a saturated marketplace.
INNOVATION
In the mid-1980s, Purdue University and African researchers developed non-chemical, three-layer storage bags, called Purdue Improved Cowpea Storage bags, or PICS bags, which work by hermetically sealing cowpeas to protect against crop losses from pests. PICS technology offers a safe, affordable storage solution for farmers that can be locally manufactured and locally procured.
GLOBAL ACCESS
To protect their crops and allow for sales when the market is favorable, the PICS storage bag technology needs to be widely accessible. This requires creating an effective and sustainable local supply chain so that PICS bags are available and affordable.
At the suggestion of an African manufacturer and distributor, the PICS brand was trademarked to provide a consistent, recognizable indicator of quality and effectiveness against pests and to encourage increased adoption.
Managing the use of the PICS trademark by local manufacturers is consistent with the principles of Global Access. The trademark provides the assurance of quality, allowing smallholder farmers to decrease crop losses and increase their income.
OUTCOME
Application of the PICS trademark helps protect against lower quality products from competitors, whose bags could jeopardize the adoption of hermetic storage solutions as an approach to mitigate crop losses.
As of 2013, 1.6 million farmers have been trained to use PICS bags, and 2.5 million bags have been sold in West Africa.
Using safe, effective, low-cost PICS bags for storage of cowpeas results in greater food security. In the 2012 to 2013 production season, PICS bags generated an increase of approximately $34 million in income for smallholder African farmers. Recently PICS bags have been successfully tested in the developing world against other insects, and will now be marketed for use for several other crops such as maize, ground nuts, and soy.
COLLABORATION FOR AIDS VACCINE DISCOVERY (CAVD)
CHALLENGE
Roughly 6,000 people become infected with HIV each day, or 2.7 million new infections per year. Worldwide, an estimated 33 million people are living with HIV/AIDS. The foundation is working to make lasting reductions in HIV infections and extend the lives of people living with HIV.
The foundation supports the improvement of treatments and diagnostic tools, expanding service delivery, and promoting effective prevention methods. But central to this strategy of defeating HIV is work to develop a preventive HIV vaccine. And despite enormous effort over more than 20 years, a vaccine that protects against HIV has yet to be produced.
Historically, HIV vaccine scientists, advocates, and funders were hindered in making faster progress by a lack of mechanisms to enable broad and effective collaboration in vaccine research and development.
INNOVATION
To accelerate the pace of HIV vaccine research, the Bill & Melinda Gates Foundation launched the CAVD Consortium in July 2006.
The CAVD operates on the principle that accelerating progress toward an AIDS vaccine requires allowing for the creativity of individual scientists, while providing a structure to enable data sharing and standardized laboratory techniques and data analysis.
The collaborative effort includes a range of innovative approaches for designing vaccine candidates, supported by expert central service facilities that enable investigators to openly share data and materials and compare results using standardized assays.
GLOBAL ACCESS
To ensure a truly collaborative effort, members of the CAVD must become a party to a standard data and material sharing agreement that allows for open communication among all investigators. Investigators share data, methods, reagents, and specimens. CAVD members also agree to grant other members a right to use all CAVD inventions for purposes of education and research in support of the development of an HIV vaccine.
In addition, members who receive funding must make a Global Access commitment that any resulting HIV vaccine will be made available and accessible at an affordable cost to people most in need within the developing world. These are the essentials tools that allow the CAVD to find a balance between open collaboration and independent research that is essential to innovation.
OUTCOME
Today, the CAVD involves more than 600 investigators from 103 institutions in 16 countries, all dedicated to designing a variety of novel HIV vaccine candidates, vaccine components, and advancing the most promising candidates to clinical trials.
REINVENT THE TOILET
CHALLENGE
Poor sanitation, a leading cause of diarrhea, contributes to 1.5 million deaths of children under the age of five every year. Chronic diarrhea can also hinder child development by impeding the absorption of essential nutrients that are critical to the development of the mind, body, and immune system. It can also impede the absorption of life-saving vaccines.
The need for better sanitation in the developing world is clear. Forty percent of the world’s population—2.5 billion people—practice open defecation or lack adequate sanitation facilities, and the consequences are devastating for human health as well as the environment.
INNOVATION
The Bill and Melinda Gates Foundation issued a challenge to researchers to develop and create innovative and affordable technologies that will radically improve sanitation in the developing world. Under the Reinvent the Toilet Challenge, the foundation is funding research to develop waterless, hygienic toilets that do not require a sewer connection or electricity and cost less than five cents per user per day.
GLOBAL ACCESS
Global Access has played a role from the beginning of the Reinvent the Toilet Challenge to ensure that these innovative solutions can ultimately have impact for those in the developing world that need them the most.
The Reinvent the Toilet Challenge funded a diverse set of partners with revolutionary ideas and as a condition of this funding, our partners made Global Access commitments.
One such commitment included granting the foundation a nonexclusive license to funded intellectual property. The purpose of this license is to enable the intended products to be made available and accessible at an affordable price to the people most in need within developing countries.
As long as Global Access is the primary goal, our partners can pursue opportunities for their innovations in the developed markets.
OUTCOME
As our partners’ efforts mature from their initial concepts towards a reinvented toilet, the Global Access commitments made at all phases of development, such as the granting of the nonexclusive license to the foundation, will help to ensure that these innovations will have made a difference for those most in need.
TUBERCULOSIS DRUG ACCELERATOR (TBDA)
CHALLENGE
Tuberculosis (TB) is one of the leading causes of death worldwide. All of the existing first-line drugs for treatment of TB are at least 40 years old, and a strict daily regimen for six to nine months is required to cure the disease. As a result, many patients end treatment prematurely, so they are not completely cured and are at risk of developing drug-resistant TB.
INNOVATION
The TB Drug Accelerator, or TBDA, was established to speed up the development of new drugs. A new combination could dramatically shorten the treatment to a few weeks, instead of six to nine months. It is an early-stage collaboration between major pharmaceutical companies and research institutions. The plan is to screen proprietary compound libraries owned by the pharmaceutical companies to identify new leads that can be optimized to yield new TB drug candidates.
GLOBAL ACCESS
The collaborators agree to share data and information that arises from TBDA activities, and to participate in the further development of new drugs derived from lead compounds identified from the proprietary pharmaceutical libraries. TBDA members also agree to grant to the other members a license to make and use all TBDA inventions for purposes of education and research. This supports the generation of new lead drug compounds for development into TB therapeutics.
As part of Global Access, the collaborators also agree that any new TB drugs developed as a result of TBDA activities will be made available and accessible at an affordable cost to the people most in need within developing countries.
OUTCOME
The goal of the TBDA is to identify five new clinical drug candidates, in the hopes of creating a new combination therapy capable of delivering a complete cure in just a few weeks versus the current minimum of six to nine months.
ENGAGED LEARNING
CHALLENGE
Only 25 percent of U.S. public high school graduates have the skills needed to succeed academically in college, which is an important gateway to economic opportunity in the United States.
By focusing on improving education through innovation — and by building on and sharing effective tools, strategies and standards – educators, school leaders, and non-profit partners across the country can transform U.S. education.
INNOVATION
Learning is improved when students are in an environment that adapts to their specific interests, pace, and learning style.
With this principle in mind, Dr. Zoran Popovic, director of the University of Washington’s Center for Game Science, founded a non-profit company called Engaged Learning. Engaged Learning is developing a platform for adaptive educational material—including digital courseware and games—that applies user data to continuously improve learning outcomes. Ultimately, it will be available for use in all educational settings, with a focus on use by students with the greatest learning needs, including low income and minority students.
The platform will have a teacher and parent portal that offers a full picture of students’ understanding of material and progress. Teachers will have access to detailed assessments that can pinpoint collective and individual learning progress in the classroom and provide real-time information on the effectiveness of classroom activities. Parents will benefit from a direct and in-depth breakdown of what their child understands and how their child learns.
GLOBAL ACCESS
To enable maximum impact, Engaged Learning made a Global Access commitment that the platform will be available and accessible at an affordable cost to state agencies, school districts, public and private school systems, and post-secondary institutions. Engaged Learning will pass this Global Access requirement along to its distribution partners, whether they are for-profit or nonprofit entities.
Engaged Learning’s Global Access commitment also includes the development of a sales and marketing strategy to increase adoption by school districts with the greatest need. In furtherance of Global Access, the Engaged Learning platform itself can adapt to any curriculum and works across all major courseware, operating systems, and device types, including mobile.
Because the knowledge and data generated are also valuable components of the platform, Engaged Learning’s Global Access commitment includes making certain anonymized data available to the foundation and to the education field for additional research and evaluation.
OUTCOME
The first release of the Engaged Learning Platform was piloted at the Washington State Algebra Challenge in June 2013, in which the DragonBox Algebra game was ported to the adaptive platform. During the one-week challenge, students from more than 70 schools across 15 school districts used the platform, achieving an average mastery rate of 93% after 1.5 hours of participation. This result is in contrast to the 40% mastery rate achieved by the standard version in a comparable amount of training.